Apixaban is an active substance from the group of anticoagulants that inhibits blood clotting. It is used to prevent the formation of thrombi and to prevent and treat thromboembolic diseases such as infarcts or embolisms. Unlike heparins, it does not have to be administrated by injection, but is taken by mouth.
Comprehensive documentation for drug registration of Apixaban can be provided by Biesterfeld as referred.
|CAS-No. || Regulatory || Monograph |
|503612-47-3 || ASMF || IH|